Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to give written consent and follow the study requirements
- People who are male and aged 18 or older at the start of the study
- People who have been diagnosed with high-risk prostate cancer confirmed by a tissue sample, meeting at least one of the following: a Gleason score of 4+4 or higher (a measure of how aggressive the cancer appears under a microscope), a PSA level of 20 or above (a protein measured in the blood related to prostate cancer), or a tumour stage of cT3a or higher (confirm with trial site)
Who may not be able to join:
- People who have a known allergy or sensitivity to the study medications or their ingredients
- People who are unable to provide written consent
- People who have another significant illness or condition that, in the trial doctor's judgment, could put them at risk or affect the study results
- People who have a history of drug or alcohol use that, in the trial doctor's judgment, could make it difficult to follow the study requirements
- People who have already started hormone therapy (androgen deprivation therapy) to reduce testosterone before joining the trial
- People who experience claustrophobia (fear of enclosed spaces), which may be relevant to certain scans used in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of subjects with local lymph node metastasi(e)s
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.